AcuraStem

Read the full announcement at: pxllnk.co/AcuraStemEurope #AcuraStem #ALS #FTD #patientbased #therapeutics #ALSresearch #drugdevelopment #AS241 #neurodegenerative #raredisease #biotech

A base inside the EU regulatory framework streamlines how we engage with regulators, funding programs, and the partners we've worked with for years.

AcuraStem's scientific roots in Europe run deep. Starting this month, so do our operational roots.

Learn more about our work at acurastem.com.

AcuraStem has received peer-reviewed grant awards from each institution across multiple funding cycles.

The NIH, DOD, and CIRM receive thousands of grant applications each year and fund the ones that demonstrate the strongest science.

ALS has resisted treatment for a long time partly because the biology is not simple. When TDP-43 breaks down in a neuron, it triggers a cascade. AcuraStem's UNC13A program targets the splicing error that cuts off a protein the synapse depends on. acurastem.com/therapeutics

Thank you to @targetALS_fdn for your continued investment in ALS drug discovery. Full press release at: pxllnk.co/TargetALSGrant

Every experiment, late-night data review, and iteration was driven by a team believing this work can help ALS patients. This grant exists because of them: Philip Wong, Wilfried Rossoll, Justin Ichida, Marcel van der Brug, Wen-Hsuan Chang, Zhihua Feng, Michelle Hung, Emily Lee.

🚨 Latest News: AcuraStem has been awarded a two-year Drug Discovery Consortium grant from Target ALS to advance therapeutics targeting SYF2, a recently identified regulator of TDP-43 function.

Why is the scientific community so focused on UNC13A? In nearly 97% of ALS cases and roughly half of FTD cases, the loss of nuclear TDP-43 triggers a critical error in the UNC13A gene. Explore the science behind our UNC13A program at acurastem.com/therapeutics. #UNC13A

#Neuroscience #EndALS #FTD #AcuraStem #PatientBased

Learn more about our mission at acurastem.com.

At AcuraStem, we believe that to truly understand human disease, we must start with human cells.